• 提示：详情请下载说明书。

• 溶解性： DMSO:  ≥  33  mg/mL

• 储存条件： -20℃

• 用途： 本品仅供科研，不得用于其它用途。

• 注意：部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。

• 7. [IF=5.4] Yingkun Sheng et al."Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway."JOURNAL OF ETHNOPHARMACOLOGY".2024 Apr;:118209

• 6. [IF=4.5] Miao Xiaolei et al."Dihydromyricetin ameliorated nonalcoholic steatohepatitis in mice by regulating the composition of serous lipids, bile acids and ileal microflora."Lipids in Health and Disease.2023 Dec;22(1):1-15

• 5. [IF=5.195] Suwen Chen et al."Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway."EUROPEAN JOURNAL OF PHARMACOLOGY.2023 Aug;952:175808

• 4. [5.168] Moath Refat et al."7, 8-Dihydroxy-4-methyl coumarin alleviates cholestasis via activation of the Farnesoid X receptor in vitro and in vivo."CHEMICO-BIOLOGICAL INTERACTIONS.2023 Jan;370:110331

• 3. [IF=3.603] Dong Si et al."Functional Amphiphilic Poly(2-oxazoline) Block Copolymers as Drug Carriers: the Relationship between Structure and Drug Loading Capacity."Chinese J Polym Sci. 2021 Jul;39(7):865-873

• 2. [IF=4.432] Guoqiang Zhang et al."Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo."Eur J Pharmacol. 2020 Oct;885:173498

• 1. Zhang, Guoqiang, et al. "Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo." European journal of pharmacology 885 (2020): 173498.https://doi.org/10.1016/j.ejphar.2020.173498

输入产品批号：

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为：

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

• pg ng μg mg g kg =
  fM pM nM μM mM M *
  nL μL mL L *